rs1042395

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The highest continental population minor allele frequency for c.668G>A (p.Arg223His) in gnomAD v2.1.1 is 0.74034 in the European non-Finnish population. This is higher than the ClinGen LSD VCEP’s BA1 threshold (>0.01), therefore meeting the BA1 criterion. There is a ClinVar entry for this variant (Variation ID: 92488; 2 star review status) with six submitters classifying the variant as benign, and one as likely benign. In summary, this variant meets the criteria to be classified as benign for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen LSD VCEP: BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA145791/MONDO:0009290/010

Frequency

Genomes: 𝑓 0.66 ( 33595 hom., cov: 33)
Exomes 𝑓: 0.71 ( 369171 hom. )

Consequence

GAA
NM_000152.5 missense

Scores

1
2
14

Clinical Significance

Benign reviewed by expert panel U:1B:16

Conservation

PhyloP100: -0.0360

Publications

61 publications found
Variant links:
Genes affected
GAA (HGNC:4065): (alpha glucosidase) This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. The encoded preproprotein is proteolytically processed to generate multiple intermediate forms and the mature form of the enzyme. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe's disease, which is an autosomal recessive disorder with a broad clinical spectrum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
GAA Gene-Disease associations (from GenCC):
  • glycogen storage disease II
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
  • glycogen storage disease due to acid maltase deficiency, infantile onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • glycogen storage disease due to acid maltase deficiency, late-onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000152.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
NM_000152.5
MANE Select
c.668G>Ap.Arg223His
missense
Exon 3 of 20NP_000143.2P10253
GAA
NM_001079803.3
c.668G>Ap.Arg223His
missense
Exon 4 of 21NP_001073271.1P10253
GAA
NM_001079804.3
c.668G>Ap.Arg223His
missense
Exon 3 of 20NP_001073272.1P10253

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
ENST00000302262.8
TSL:1 MANE Select
c.668G>Ap.Arg223His
missense
Exon 3 of 20ENSP00000305692.3P10253
GAA
ENST00000390015.7
TSL:1
c.668G>Ap.Arg223His
missense
Exon 4 of 21ENSP00000374665.3P10253
GAA
ENST00000933406.1
c.668G>Ap.Arg223His
missense
Exon 3 of 20ENSP00000603465.1

Frequencies

GnomAD3 genomes
AF:
0.657
AC:
99833
AN:
151982
Hom.:
33582
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.536
Gnomad AMI
AF:
0.649
Gnomad AMR
AF:
0.559
Gnomad ASJ
AF:
0.770
Gnomad EAS
AF:
0.539
Gnomad SAS
AF:
0.658
Gnomad FIN
AF:
0.775
Gnomad MID
AF:
0.839
Gnomad NFE
AF:
0.736
Gnomad OTH
AF:
0.667
GnomAD2 exomes
AF:
0.666
AC:
162329
AN:
243594
AF XY:
0.681
show subpopulations
Gnomad AFR exome
AF:
0.538
Gnomad AMR exome
AF:
0.474
Gnomad ASJ exome
AF:
0.779
Gnomad EAS exome
AF:
0.528
Gnomad FIN exome
AF:
0.752
Gnomad NFE exome
AF:
0.740
Gnomad OTH exome
AF:
0.720
GnomAD4 exome
AF:
0.711
AC:
1030164
AN:
1448490
Hom.:
369171
Cov.:
58
AF XY:
0.712
AC XY:
512807
AN XY:
720028
show subpopulations
African (AFR)
AF:
0.539
AC:
17981
AN:
33368
American (AMR)
AF:
0.489
AC:
21802
AN:
44582
Ashkenazi Jewish (ASJ)
AF:
0.782
AC:
20386
AN:
26068
East Asian (EAS)
AF:
0.559
AC:
22109
AN:
39564
South Asian (SAS)
AF:
0.670
AC:
57680
AN:
86142
European-Finnish (FIN)
AF:
0.760
AC:
34338
AN:
45174
Middle Eastern (MID)
AF:
0.794
AC:
4121
AN:
5188
European-Non Finnish (NFE)
AF:
0.730
AC:
809122
AN:
1108302
Other (OTH)
AF:
0.709
AC:
42625
AN:
60102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
16408
32815
49223
65630
82038
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19910
39820
59730
79640
99550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.657
AC:
99875
AN:
152100
Hom.:
33595
Cov.:
33
AF XY:
0.654
AC XY:
48653
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.536
AC:
22228
AN:
41480
American (AMR)
AF:
0.558
AC:
8525
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.770
AC:
2671
AN:
3468
East Asian (EAS)
AF:
0.539
AC:
2787
AN:
5174
South Asian (SAS)
AF:
0.657
AC:
3162
AN:
4814
European-Finnish (FIN)
AF:
0.775
AC:
8213
AN:
10594
Middle Eastern (MID)
AF:
0.847
AC:
249
AN:
294
European-Non Finnish (NFE)
AF:
0.736
AC:
50039
AN:
67972
Other (OTH)
AF:
0.667
AC:
1409
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1696
3392
5088
6784
8480
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
806
1612
2418
3224
4030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.694
Hom.:
88041
Bravo
AF:
0.637
TwinsUK
AF:
0.723
AC:
2681
ALSPAC
AF:
0.724
AC:
2792
ESP6500AA
AF:
0.544
AC:
2396
ESP6500EA
AF:
0.738
AC:
6348
ExAC
AF:
0.675
AC:
81893
Asia WGS
AF:
0.580
AC:
2021
AN:
3476
EpiCase
AF:
0.742
EpiControl
AF:
0.742

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
Glycogen storage disease, type II (7)
-
-
5
not specified (5)
-
1
3
not provided (4)
-
-
1
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
17
DANN
Benign
0.80
DEOGEN2
Uncertain
0.46
T
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.66
T
MetaRNN
Benign
0.000017
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Pathogenic
3.3
M
PhyloP100
-0.036
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-1.6
N
REVEL
Uncertain
0.39
Sift
Benign
0.54
T
Sift4G
Benign
0.29
T
Polyphen
0.21
B
Vest4
0.050
MPC
0.14
ClinPred
0.033
T
GERP RS
1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.23
gMVP
0.69
Mutation Taster
=55/45
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1042395; hg19: chr17-78079669; COSMIC: COSV56406846; COSMIC: COSV56406846; API